Perhexiline is an orally active inhibitor of CPT1 and CPT2 that reduces fatty acid metabolism. Perhexiline can cross the blood-brain barrier (BBB) and exhibits anti-tumor activity. Perhexiline induces mitochondrial dysfunction and apoptosis in hepatocytes. Therefore, Perhexiline can be used in cancer and cardiovascular disease research [1] [2] [5].
Molecular Weight:
277.49
CAS Number:
[6621-47-2]
Formula:
C19H35N
Target:
Others|||Apoptosis|||Mitochondrial Metabolism
T60510
* VAT and and shipping costs not included. Errors and price changes excepted